These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34160770)

  • 1. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
    Ding YY; Ren Y; Qin J; Qian GH; Tang YJ; Chen Y; Li X; Xu L; Qiao CH; Sun L; Lv HT
    World J Pediatr; 2021 Jun; 17(3):263-271. PubMed ID: 34160770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycoplasma pneumoniae detections in children with lower respiratory infection before and during the COVID-19 pandemic: a large sample study in China from 2019 to 2022.
    Qiu W; Ding J; Zhang H; Huang S; Huang Z; Lin M; Zhang Y; Chen Z
    BMC Infect Dis; 2024 Jun; 24(1):549. PubMed ID: 38824572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory pathogen trends in patients with Kawasaki disease during the COVID-19 pandemic and respiratory syncytial virus epidemic in Japan.
    Namba T; Higuchi Y; Shimizu J
    Pediatr Neonatol; 2023 Sep; 64(5):505-511. PubMed ID: 36878812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological Study on
    Cai F; Shou X; Ye Q
    Front Cell Infect Microbiol; 2022; 12():843463. PubMed ID: 35386684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
    Hara T; Furuno K; Yamamura K; Kishimoto J; Mizuno Y; Murata K; Onoyama S; Hatae K; Takemoto M; Ishizaki Y; Kanno S; Sato K; Motomura Y; Sakai Y; Ohga S; Yashiro M; Nakamura Y; Hara T
    JAMA Netw Open; 2021 Apr; 4(4):e214475. PubMed ID: 33822065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease associated with Mycoplasma pneumoniae.
    Tang Y; Yan W; Sun L; Huang J; Qian W; Hou M; Lv H
    Ital J Pediatr; 2016 Sep; 42(1):83. PubMed ID: 27609267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of pathogenic agents causing acute respiratory tract infections in pediatric patients in a children's hospital assigned for case screening in Beijing during the outbreak of COVID-19].
    Zhao LQ; Deng L; Cao L; Chen DM; Sun Y; Zhu RN; Wang F; Guo Q; Zhou YT; Jia LP; Huang H; Kang XH; Jin FH; Yuan Y; Zhang N; De R; Qian Y
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):635-639. PubMed ID: 32842383
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
    Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
    Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
    Iio K; Matsubara K; Miyakoshi C; Ota K; Yamaoka R; Eguchi J; Matsumura O; Okutani T; Ueda I; Nishiyama M
    BMJ Paediatr Open; 2021; 5(1):e001034. PubMed ID: 33884312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.
    Lan Y; Li S; Yang D; Zhou J; Wang Y; Wang J; Xu Y; Chen Z
    Medicine (Baltimore); 2020 May; 99(19):e19987. PubMed ID: 32384451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.
    Burney JA; Roberts SC; DeHaan LL; Shimizu C; Bainto EV; Newburger JW; Dominguez S; Jone PN; Jaggi P; Szmuszkovicz JR; Rowley AH; Samuy N; Scalici P; Tremoulet AH; Cayan DR; Burns JC;
    JAMA Netw Open; 2022 Jun; 5(6):e2217436. PubMed ID: 35713905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
    Tang ML; Li YQ; Chen X; Lin H; Jiang ZC; Gu DL; Chen X; Tang CX; Xie ZQ
    Med Sci Monit; 2021 Jan; 27():e929783. PubMed ID: 33388738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunologic Profiles of Kawasaki Disease Triggered by Mycoplasma pneumoniae Infection.
    Hu HB; Shang XP; Wu JG; Cai YL
    Fetal Pediatr Pathol; 2023 Jun; 42(3):376-384. PubMed ID: 36484731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of COVID-19 on Kawasaki Disease: Decrease Age of Onset and Increase Skin Manifestation.
    Esmaeilzadeh H; Mortazavi N; Salehi A; Fatemian H; Dehghani SM; Vali M; Vardanjani HM
    BMC Pediatr; 2021 Dec; 21(1):571. PubMed ID: 34903208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    Ishii T; Nawa N; Hosokawa S; Morio T; Fujiwara T
    J Med Virol; 2024 May; 96(5):e29660. PubMed ID: 38727136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
    Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
    [No Abstract]   [Full Text] [Related]  

  • 17. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
    Verdoni L; Mazza A; Gervasoni A; Martelli L; Ruggeri M; Ciuffreda M; Bonanomi E; D'Antiga L
    Lancet; 2020 Jun; 395(10239):1771-1778. PubMed ID: 32410760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.
    Toubiana J; Cohen JF; Brice J; Poirault C; Bajolle F; Curtis W; Moulin F; Matczak S; Leruez M; Casanova JL; Chalumeau M; Taylor M; Allali S
    J Clin Immunol; 2021 Apr; 41(3):526-535. PubMed ID: 33394320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic.
    Ono R; Hasegawa D
    World J Pediatr; 2021 Apr; 17(2):215-217. PubMed ID: 33548034
    [No Abstract]   [Full Text] [Related]  

  • 20. Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era.
    Phamduy TT; Smith S; Herbst KW; Phamduy PT; Brimacombe M; Hogan AH; Salazar JC; Sturm J
    Pediatr Infect Dis J; 2021 Nov; 40(11):e407-e412. PubMed ID: 34382611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.